Patent · US Active

Spectinamides as anti-tuberculosis agents

US8685978B2 · kind B2 · utility

1Cited by

3References

24Claims

0Family size

Assignee

University of Tennessee Research Foundation · US

Inventors

Richard E. Lee · Cordova, US
Jianjun Qi · Houston, US
Julian G. Hurdle · Euless, US
Bernd Meibohm · Germantown, US
VNR Pavan Kumar Vaddady · Memphis, US
Jiuyu Rakesh · Cordova, US
Jiuyu Liu · Beijing, CN

Key dates

Filing date	Jul 26, 2010
Grant date	Apr 1, 2014
Priority date	—
Expiry date	Jul 16, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Novel 3′-deoxy-3′-acylaminospectinomycin compounds are described. Also described are methods of using the 3′-deoxy-3-acylaminospectinomycin compounds and other spectinomycin analogs in treating tuberculosis and in treating microbial infections.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.